Open AccessHumanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon
Author(s) -
B. Bielekova,
N. Richert,
Tatianna Howard,
G. Blevins,
S. Markovic-Plese,
J. McCartin,
J. Wurfel,
J. Ohayon,
T. A. Waldmann,
H. F. McFarland,
R. Martin
Publication year - 2004
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/mqbh-m574
Subject(s) - daclizumab , multiple sclerosis , interferon , medicine , disease , immunology , interferon beta , monoclonal antibody , antibody
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom